Red: I get your point. AMBS has been making progress this past year, no doubt. We started the year at about .08 cents with about 600 million outstanding shares giving us a market cap of 48 million. Today we are still trading at .08 cents but have nearly 900 million outstanding shares, giving us a market cap today of 72 million. So in 2014 AMBS' market cap grew by 24 million dollars from 48 million to 72 million. That's pretty good. Gerald has been bringing along our pipeline. But as far as shareholder's value....we haven't seen an increase in 2014.
I think this is the concern for some: that management will continue using dilution to grow the company at the expense of current shareholder's value. Some like Jacmar delight in the thought our pps remains at .08 cents for another couple of years so her Amgen dividends enable her to accumulate more shares in AMBS. But Jacmar's Investor Profile is very different than mine and JPs. We need to see an increase in pps by January or February.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links